Can neurotechnology revolutionize cognitive enhancement?


Journal

PLoS biology
ISSN: 1545-7885
Titre abrégé: PLoS Biol
Pays: United States
ID NLM: 101183755

Informations de publication

Date de publication:
Oct 2024
Historique:
medline: 29 10 2024
pubmed: 29 10 2024
entrez: 29 10 2024
Statut: epublish

Résumé

The development and implementation of neurotechnology for cognitive enhancement could spearhead a new wave of innovation in the information age. However, we argue here that this will only happen with a more fundamental understanding of human brain function.

Identifiants

pubmed: 39471132
doi: 10.1371/journal.pbio.3002831
pii: PBIOLOGY-D-24-02142
pmc: PMC11521288
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e3002831

Informations de copyright

Copyright: © 2024 Violante, Okyere. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Front Syst Neurosci. 2021 Feb 25;15:578875
pubmed: 33716680
Commun Biol. 2023 Jan 6;6(1):14
pubmed: 36609559
Nat Rev Neurosci. 2024 Jul;25(7):473-492
pubmed: 38745103
Front Hum Neurosci. 2019 Jan 31;13:13
pubmed: 30766483
Science. 2022 Nov 25;378(6622):835-838
pubmed: 36423271
Neuroscientist. 2022 Aug;28(4):382-399
pubmed: 33593120
Clin Neurophysiol Pract. 2022 May 25;7:146-165
pubmed: 35734582

Auteurs

Ines R Violante (IR)

School of Psychology, Faculty of Health and Medical Sciences, University of Surrey, Guildford, United Kingdom.
School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom.

Prince Okyere (P)

School of Psychology, Faculty of Health and Medical Sciences, University of Surrey, Guildford, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH